Towards an Architecture to Guarantee Both Data Privacy and Utility in the First Phases of Digital Clinical Trials
- PMID: 30487435
- PMCID: PMC6308650
- DOI: 10.3390/s18124175
Towards an Architecture to Guarantee Both Data Privacy and Utility in the First Phases of Digital Clinical Trials
Abstract
In the era of the Internet of Things (IoT), drug developers can potentially access a wealth of real-world, participant-generated data that enable better insights and streamlined clinical trial processes. Protection of confidential data is of primary interest when it comes to health data, as medical condition influences daily, professional, and social life. Current approaches in digital trials entail that private user data are provisioned to the trial investigator that is considered a trusted party. The aim of this paper is to present the technical requirements and the research challenges to secure the flow and control of personal data and to protect the interests of all the involved parties during the first phases of a clinical trial, namely the characterization of the potential patients and their possible recruitment. The proposed architecture will let the individuals keep their data private during these phases while providing a useful sketch of their data to the investigator. Proof-of-concept implementations are evaluated in terms of performances achieved in real-world environments.
Keywords: IoT; human-centered computing; mobile devices; performance evaluation; privacy protection; security; survey.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Device-Based Security to Improve User Privacy in the Internet of Things †.Sensors (Basel). 2018 Aug 14;18(8):2664. doi: 10.3390/s18082664. Sensors (Basel). 2018. PMID: 30110880 Free PMC article.
-
Ethical Design in the Internet of Things.Sci Eng Ethics. 2018 Jun;24(3):905-925. doi: 10.1007/s11948-016-9754-5. Epub 2016 Jan 21. Sci Eng Ethics. 2018. PMID: 26797878 Free PMC article.
-
Searchable Encryption Scheme for Personalized Privacy in IoT-Based Big Data.Sensors (Basel). 2019 Mar 1;19(5):1059. doi: 10.3390/s19051059. Sensors (Basel). 2019. PMID: 30832294 Free PMC article.
-
Privacy and the Internet of Things (IoT) Monitoring Solutions for Older Adults: A Review.Stud Health Technol Inform. 2018;252:8-14. Stud Health Technol Inform. 2018. PMID: 30040675 Review.
-
Developing a System for Processing Health Data of Children Using Digitalized Toys: Ethical and Privacy Concerns for the Internet of Things Paradigm.Sci Eng Ethics. 2018 Aug;24(4):1057-1076. doi: 10.1007/s11948-017-9951-x. Epub 2017 Aug 16. Sci Eng Ethics. 2018. PMID: 28815460 Review.
Cited by
-
An empirical investigation into the altering health perspectives in the internet of health things.Int J Inf Technol. 2023;15(1):67-77. doi: 10.1007/s41870-022-01035-3. Epub 2022 Jul 18. Int J Inf Technol. 2023. PMID: 35874858 Free PMC article.
-
METORY: Development of a Demand-Driven Blockchain-Based Dynamic Consent Platform Tailored for Clinical Trials.Front Med (Lausanne). 2022 May 13;9:837197. doi: 10.3389/fmed.2022.837197. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35646983 Free PMC article.
References
-
- Jara A.J., Zamora M.A., Skarmeta A.F.G. An internet of things–based personal device for diabetes therapy management in ambient assisted living (AAL) Personal Ubiquit. Comput. 2011;15:431–440. doi: 10.1007/s00779-010-0353-1. - DOI
-
- DiMasi J.A., Grabowski H.G., Hansen R.W. Innovation in the pharmaceutical industry: New estimates of R&D costs. J. Health Econ. 2016;47:20–33. - PubMed
-
- Trends, Charts, and Maps at ClinicalTrials.gov. [(accessed on 1 September 2018)]; Available online: https://clinicaltrials.gov/ct2/resources/trends.
-
- The Center for Information and Study on Clinical Research Participation (CISCRP) [(accessed on 1 November 2018)]; Available online: https://www.ciscrp.org.
MeSH terms
LinkOut - more resources
Full Text Sources
Molecular Biology Databases